Benchmark

According to a research report released today by Benchmark, The McGraw-Hill Companies, Inc. (NYSE: MHP) reported 4Q11 results with EPS above expectations due to cost reductions. Benchmark went on to explain, “McGraw-Hill Financial had flat y/y revenue in 4Q11 at $1 billion. S&P ratings revenue...

In a recent research report published by Benchmark, Exxon Mobil's (NYSE: XOM) adjusted 4Q results of $1.70 per share was significantly below estimates. In the report, Benchmark commented, “On a preliminary basis, we expect to lower our full year 2012 estimate by 5% - 8%, with the reductions...

Benchmark initiates its coverage on Zillow (NASDAQ: Z) with a Buy rating and a target price of $35 a share on the company entering early stage of sustainable high growth. Benchmark comments, "Zillow is a high-growth, high-multiple stock with a small penetration of a vast market. We expect...

Benchmark reiterates its Buy rating on Equinix (NASDAQ: EQIX) and raises its price target to $140 (previously $115) as the company is on course to achieve FCF and convert to REIT. Benchmark says, "Equinix stock has risen on sustained demand trends, solid growth prospects, visibility to achieving...

Benchmark reiterates its Buy rating and $18 target price on Gannett (NYSE: GCI) as the company's outlook remains unchanged, despite 4Q results that disappoint. Benchmark says, "Management did not provide guidance, but noted that the Publishing outlook appeared better while Career Builder remains...

Benchmark lowers its rating on The Pep Boys (NYSE: PBY) to Hold as the company receives a $15/share bid in cash, which becomes the new target on shares (from $14 previously). Benchmark says, "Despite a low valuation, for a takeout, we have no reason to believe a competing offer will be made....

Benchmark reiterates its Hold rating and $28 target price on FLIR Systems (NASDAQ: FLIR) as the company is likely to report in line for its Q4, following a lowered guidance in October. Benchmark says, "We believe FLIR will likely report an in-line Q4 following its lowered guidance in October....

Benchmark reiterates its Hold rating on Manhattan Associates (NASDAQ: MANH) as the company is set to report on 4Q11 after market close tonight. Benchmark says, "We expect the Company to deliver total revenue and license revenue relatively in line with our estimates of $85 million and $16 million...

According to Benchmark, Travelzoo (NASDAQ: TZOO) is downgraded to Hold. Benchmark said that it is downgrading shares of Travelzoo (TZOO – PT from $37 to $30) from Buy to Hold following disappointing 4Q11 results. “Net revenue grew by 23.5% y/y to $35.2 million, a marked deceleration from the 40% y...

Benchmark reiterates its Hold rating on Marchex (NASDAQ: MCHX) but lowers its price rating to $4 on a rapidly deteriorating click activity. Benchmark says, " Marchex's pay-per-click revenue rapidly deteriorated in 4Q11. The pay-per-click revenue likely declines further in 2012. We estimate 2012...

Benchmark maintains its Hold rating on Google (NASDAQ: GOOG) and lowers its price target to $625 from $700 a share following the company's miss on revenues driven largely by Europe. Benchmark says, " Google reported 4Q11 results that missed consensus estimates meaningfully. International y/y...

Benchmark reiterates its Buy rating on OSI Systems (NASDAQ: OSIS) and raises its price target to $66 on security and healthcare upside in 2012 and 2013. Benchmark notes, "OSI reported a strong Q2 and raised FY12 guidance, as we expected. Q2 revenue and EPS were $188 million and $0.61 vs....

According to a research report published by Benchmark today, Oshkosh Corporation (NYSE: OSK) is likely to report an in-line or better quarter on Tuesday, January 31. In the report, Benchmark comments, “We expect OSK to report an in-line or potentially better than expected quarter. This is based...

Benchmark has reiterated its Buy rating for Broadcom Corporation (NASDAQ: BRCM) ahead of 4Q11 results, which are expected to be published Tuesday, January 31. According to the report, Benchmark said, “Given that management provided a 4Q11 financial update on December 14, investors are primarily...

According to Benchmark, Synergetics USA (NASDAQ: SURG) hosted an investor tour yesterday in order to discuss management's long term strategies and preview neurosurgery products in development. Beyond the optimistic outlook gained, Benchmark noted, “This month we identified Synergetics as one of...